Epigral has informed that pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company will be held on Saturday, 2nd August, 2025, at the Registered Office of the Company, to consider Un-audited Financial Results (Standalone & Consolidated) of the Company for the First Quarter ended on 30th June, 2025 and to take on record the Limited Review Report of the Statutory Auditors thereon; evaluate and approve the proposal for raising of funds by way of issue of nonconvertible debentures, bonds and/or other debt securities etc. through permissible mode(s), subject to such regulatory and other approvals as may be required in this regard; and any other business with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.
